Novartis India Ltd vs Pfizer Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 12, 2026

Key Highlights

The Latest Trading Price of Novartis India Ltd is ₹ 1259 as of 12 May 15:30 . The P/E Ratio of Novartis India Ltd changed from 65.2 on March 2021 to 19.2 on March 2025 . This represents a CAGR of -21.69% over 5 yearsThe P/E Ratio of Pfizer Ltd changed from 41.6 on March 2021 to 23.9 on March 2025 . This represents a CAGR of -10.49% over 5 years The Market Cap of Novartis India Ltd changed from ₹ 1362 crore on March 2021 to ₹ 1938 crore on March 2025 . This represents a CAGR of 7.30% over 5 yearsThe Market Cap of Pfizer Ltd changed from ₹ 20684 crore on March 2021 to ₹ 18317 crore on March 2025 . This represents a CAGR of -2.40% over 5 years The revenue of Novartis India Ltd for the Mar '26 is ₹ 100.56 crore as compare to the Dec '25 revenue of ₹ 94.65 crore. This represent the growth of 6.24% The revenue of Pfizer Ltd for the Mar '26 is ₹ 678.99 crore as compare to the Dec '25 revenue of ₹ 683.24 crore. This represent the decline of -0.62% The ebitda of Novartis India Ltd for the Mar '26 is ₹ 30.63 crore as compare to the Dec '25 ebitda of ₹ 31.11 crore. This represent the decline of -1.54% The ebitda of Pfizer Ltd for the Mar '26 is ₹ 285.71 crore as compare to the Dec '25 ebitda of ₹ 208.2 crore. This represent the growth of 37.23% The net profit of Novartis India Ltd changed from ₹ 25.74 crore to ₹ 25.25 crore over 8 quarters. This represents a CAGR of -0.96% The net profit of Pfizer Ltd changed from ₹ 150.71 crore to ₹ 199.82 crore over 8 quarters. This represents a CAGR of 15.15% The Dividend Payout of Novartis India Ltd changed from 118.09 % on March 2021 to 61.15 % on March 2025 . This represents a CAGR of -12.33% over 5 yearsThe Dividend Payout of Pfizer Ltd changed from 32.18 % on March 2021 to 98.34 % on March 2025 . This represents a CAGR of 25.03% over 5 years .

About Novartis India Ltd

Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.

About Pfizer Ltd

Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories.
It has its own manufacturing facility at Goa and Thane.
It has the distinction of being the first pharmaceutical company in India to start clinical research.
The Company sells products in nearly 185 countries having 43 manufacturing sites globally.

FAQs for the comparison of Novartis India Ltd and Pfizer Ltd

Which company has a larger market capitalization, Novartis India Ltd or Pfizer Ltd?

Market cap of Novartis India Ltd is 3,108 Cr while Market cap of Pfizer Ltd is 21,633 Cr

What are the key factors driving the stock performance of Novartis India Ltd and Pfizer Ltd?

The stock performance of Novartis India Ltd and Pfizer Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Novartis India Ltd and Pfizer Ltd?

As of May 12, 2026, the Novartis India Ltd stock price is INR ₹1259.05. On the other hand, Pfizer Ltd stock price is INR ₹4728.9.

How do dividend payouts of Novartis India Ltd and Pfizer Ltd compare?

To compare the dividend payouts of Novartis India Ltd and Pfizer Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.